Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Trinity Biotech (TRIBY) -- Ignore unavailable to you. Want to Upgrade?

To: Keiko who wrote (8506)	3/11/1998 10:17:00 PM
From: DMore	Read Replies (1) \| Respond to of 14328

What ever happened to the story in the medical journal, about the CDC and POC testing? Is it out or when will it be? D

To: Keiko who wrote (8506)	3/12/1998 2:15:00 AM
From: milton	Read Replies (1) \| Respond to of 14328

Keiko: It's good to be back. I've missed this board as I have been stranded out of town for the last several weeks. Triby's doing remarkable in the news but the price just doesn't show it yet. My check of the broker's screen today sowed a report of the closure of a London Centcor lab in a cost reduction move, and a shifting of production to existing Dublin facilities with more upgrading. All the news shows more efficiencies, product expansion, and incredible continuing revenues and profits growth. Confirming my earlier concerns is the comment from one broker today that $5 is the floor before brokers can begin recommending the stock to their clients in most of the major brokerage firms. Triby has to break that ceiling if it wants to move into a better trading strata. Then we'll see better activity. Also, if the 1998 projections hold up at 15 cents per share, then at 20~ 30 X earnings, I expect $4.50. If earnings trends are higher, then the price should be higher.